Targeted treatment for fragile X syndrome: results of a randomized controlled phase II trial of arbaclofen

被引：0

作者：

Hagerman, Randi ^{[1
,2
]}

Rathmell, Barbara ^{[3
]}

Wang, Lulu ^{[1
,2
]}

Carpenter, Randy ^{[3
]}

Wang, Paul ^{[3
]}

Berry-Kravis, Elizabeth ^{[4
]}

机构：

[1] UC Davis Med Ctr, MIND Inst, Sacramento, CA USA

[2] UC Davis Med Ctr, Dept Pediat, Sacramento, CA USA

[3] Seaside Therapeut, Boston, MA USA

[4] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA

来源：

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2010年 / 54卷

关键词：

fragile X syndrome; targeted treatments; GABA; arbaclofen;

D O I：

暂无

中图分类号：

G76 [特殊教育];

学科分类号：

040109 ;

摘要：

引用

页码：884 / 884

页数：1

共 50 条

[41] Lithium: A Promising Treatment for Fragile X Syndrome
Liu, Zhonghua
Smith, Carolyn Beebe
ACS CHEMICAL NEUROSCIENCE, 2014, 5 (06): : 477 - 483
[42] A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome
de la Torre, Rafael
de Sola, Susana
Farre, Magi
Xicota, Laura
Cuenca-Royo, Aida
Rodriguez, Joan
Leon, Alba
Langohr, Klaus
Gomis-Gonzalez, Maria
Hernandez, Gimena
Esteba, Susanna
del Hoyo, Laura
Sanchez-Gutierrez, Judit
Jose Cortes, Maria
Ozaita, Andres
Maria Espadaler, Josep
Novell, Ramon
Martinez-Leal, Rafael
Mila, Montserrat
Dierssen, Mara
CLINICAL NUTRITION, 2020, 39 (02) : 378 - 387
[43] Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
Angela John Thurman
Laura A. Potter
Kyoungmi Kim
Flora Tassone
Amy Banasik
Sarah Nelson Potter
Lauren Bullard
Vivian Nguyen
Andrea McDuffie
Randi Hagerman
Leonard Abbeduto
Journal of Neurodevelopmental Disorders, 2020, 12
[44] Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
Thurman, Angela John
Potter, Laura A.
Kim, Kyoungmi
Tassone, Flora
Banasik, Amy
Potter, Sarah Nelson
Bullard, Lauren
Nguyen, Vivian
McDuffie, Andrea
Hagerman, Randi
Abbeduto, Leonard
JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2020, 12 (01)
[45] Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments
Salcedo-Arellano, Maria Jimena
Cabal-Herrera, Ana Maria
Punatar, Ruchi Harendra
Clark, Courtney Jessica
Romney, Christopher Allen
Hagerman, Randi J.
NEUROTHERAPEUTICS, 2021, 18 (01) : 265 - 283
[46] Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome
Berry-Kravis, Elizabeth
Sumis, Allison
Hervey, Crystal
Nelson, Michael
Porges, Stephen W.
Weng, Ning
Weiler, Ivan Jeanne
Greenough, William T.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2008, 29 (04) : 293 - 302
[47] Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments
Maria Jimena Salcedo-Arellano
Ana Maria Cabal-Herrera
Ruchi Harendra Punatar
Courtney Jessica Clark
Christopher Allen Romney
Randi J Hagerman
Neurotherapeutics, 2021, 18 : 265 - 283
[48] Serotonin dysregulation in Fragile X Syndrome: implications for treatment
Hanson, Alicia C.
Hagerman, Randi J.
INTRACTABLE & RARE DISEASES RESEARCH, 2014, 3 (04) : 110 - 117
[49] Caregiver Preferences for the Treatment of Males with Fragile X Syndrome
Cross, James
Yang, Jui-Chen
Johnson, F. Reed
Quiroz, Jorge
Dunn, Judith
Raspa, Melissa
Bailey, Donald B., Jr.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2016, 37 (01) : 71 - 79
[50] Emerging pharmacologic treatment options for fragile X syndrome
Schaefer, Tori L.
Davenport, Matthew H.
Erickson, Craig A.
APPLICATION OF CLINICAL GENETICS, 2015, 8 : 75 - 93

← 1 2 3 4 5 →